Search results
Psoriasis and Depression: What’s the Connection?
Verywell Health via Yahoo News· 2 days agoPsoriasis is a chronic skin condition that can affect your mood, and many people with psoriasis experience depression. Here’s what you can do if you feel...
Ted Danson Has Lived With Psoriasis for 50 Years—Here Are the Dermatologist-Approved Ways He Combats...
Eating Well via Yahoo News· 6 days agoActor Ted Danson and dermatologist Jennifer Soung shared the importance of seeking care for...
How Does Psoriasis Affect Pregnancy?
Verywell Health via Yahoo News· 6 days agoExperiencing psoriasis during pregnancy is unlikely to pose a risk for your fetus, but it can affect each person differently. Here’s what you need to...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 5 days agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
Experts Share How to Do a Hot Oil Treatment for Hair at Home
Prevention via AOL· 1 day agoIt can also just... feel nice. Boost blood flow to scalp You may have heard that hot oil treatments...
Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer
Morningstar· 7 days agoOruka Therapeutics, Inc. (“Oruka”), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including ...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 4 days agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 5 days agoLOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of Ventyx Biosciences, Inc. (“Ventyx”
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 22 hours agoA decision on approval is expected in the fourth quarter of 2024.
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...